The Q4 beat on sales and EBITDA vs guidance is a positive, but full-year earnings declined sharply and FY2027 guidance implies only modest growth. The divergence between strong North America performance and deteriorating International results (EMEA/Middle East) remains the key risk. Watch for updates on the strategic review and Investor Day in early calendar 2027 for potential portfolio actions.
Price Chart
Executive Summary
Lamb Weston reported Q4 fiscal 2026 results with net sales of $1.77B and adjusted diluted EPS of $0.87, exceeding the high end of its guidance for both net sales and Adjusted EBITDA. Full-year net sales grew 2% to $6.61B, but full-year net income declined 19% and Adjusted EBITDA fell 9% due to ongoing challenges in the International segment, including Middle East disruption and input cost inflation. The company provided fiscal 2027 guidance for net sales growth of 0-1% and Adjusted EBITDA of $1.1B-$1.2B, signaling a stabilization but no immediate recovery in profitability.
Key Financial Metrics
Key Facts
- Q4 net sales $1.77B, +6% YoY, exceeding guidance high end of $6.55B for the full year.
- Q4 adjusted diluted EPS $0.87, -5% YoY; full-year adjusted diluted EPS $3.01, -16% YoY.
- Full-year Adjusted EBITDA $1.147B, -9% YoY, but exceeded guidance high end of $1.14B.
- North America segment Q4 Adjusted EBITDA +17% YoY to $305M; International segment Q4 Adjusted EBITDA -81% YoY to $12M.
- Fiscal 2027 guidance: net sales growth 0-1% (52-week adjusted), Adjusted EBITDA $1.1B-$1.2B, Adjusted Diluted EPS $2.95-$3.25.
- Company returned $320.7M to shareholders in FY2026 via dividends and buybacks; $245M remains authorized for repurchase.
- Cost savings program exceeded $100M milestone in FY2026; targeting $250M annualized run-rate savings by FY2028.
Financial Impact
Full-year net sales $6.61B (+2% YoY), net income $290M (-19% YoY), Adjusted EBITDA $1.147B (-9% YoY). Q4 net sales $1.77B (+6% YoY), net income $110M (-9% YoY), Adjusted EBITDA $288M (-2% YoY).
Risk Factors
- Continued weakness in International segment, particularly EMEA due to Middle East conflict and competitive pressures.
- Input cost inflation and unfavorable pricemix pressuring margins despite cost savings.
- FY2027 guidance implies net sales growth of only 0-1% (52-week adjusted), suggesting limited top-line momentum.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001679273-26-000024 |
| Document: lw-20260724.htm | 0001679273-26-000024 |
| Document: 0001679273-26-000024-index-headers.html | 0001679273-26-000024 |
| Document: 0001679273-26-000024-index.html | 0001679273-26-000024 |
| Document: 0001679273-26-000024.txt | 0001679273-26-000024 |
| 8-K Data (Synthetic) | 0001679273-26-000024 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 30, 2026 9w ago | DEFA14A | $53.55 $54.80 | ▲ +2.33% | ▼ −1.63% | $43.60 (−18.58%) |
Jul 24, 2026 10w ago | 8-K | $49.58 $53.68 | ▲ +8.27% | ▲ +4.64% | $43.60 (−12.06%) |
Jul 15, 2026 11w ago | 8-K | $46.92 $53.78 | ▲ +14.62% | ▲ +11.00% | $43.60 (−7.08%) |
Jun 4, 2026 17w ago | 8-K | $42.18 $45.91 | ▼ −8.84% | ▼ −10.47% | $43.60 (−3.37%) |
May 26, 2026 18w ago | 8-K | $42.10 $44.88 | ▲ +6.60% | ▲ +8.87% | $43.60 (+3.56%) |
Apr 6, 2026 25w ago | Insider Cluster | $40.14 $42.51 | ▲ +5.90% | ▼ −3.08% | $43.60 (+8.62%) |
Apr 6, 2026 25w ago | Insider Cluster | $40.14 $42.51 | ▲ +5.90% | ▼ −3.08% | $43.60 (+8.62%) |
Apr 1, 2026 26w ago | 8-K | $38.45 $43.03 | ▲ +11.91% | ▲ +2.19% | $43.60 (+13.39%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access